Drug Profile


Latest Information Update: 28 Jan 2015

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Nonindustrial source
  • Developer Nonindustrial source; Slovakofarma
  • Class Anti-ischaemics; Antiarrhythmics; Antipsychotics; Carbolines; Indoles; Ischaemic heart disorder therapies; Pyridones; Radioprotectives; Small molecules
  • Mechanism of Action Antioxidants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Arrhythmias; Diabetic complications; Ischaemic heart disorders; Radiation injuries

Most Recent Events

  • 07 May 2003 Discontinued - Preclinical for Diabetic complications in Slovakia (unspecified route)
  • 25 Jun 2001 No-Development-Reported for Radiation injuries/Radioprotection in Slovakia (Unknown route)
  • 13 Jun 2001 No-Development-Reported for Diabetic complications in Slovakia (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top